Diabetic Ketoacidosis clinical trials

Explore recruiting diabetic ketoacidosis clinical trials.

Recruiting diabetic ketoacidosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Diabetic Ketoacidosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Comparison of isotonic saline and Ringer lactate in the management of severe diabetic ketoacidosis: a double-blind randomized controlled trial.

France

Therapeutic use (Phase IV) EU CTIS Study details

Intraclass safety and efficacy comparison among SGLT-2 inhibitors in elderly patients with type 2 diabetes. A pragmatic, phase IV, multicenter, open-label, randomised controlled trial.

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Obesity and Semaglutide in Type 1 Diabetes Therapy (OBES1TY): A Multicentre, Randomised, Double-Blinded, Placebo-Controlled, Investigator-Initiated Trial

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes (REC1TE): a randomized, double-blind, placebo-controlled, investigator-initiated trial

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

An open-label extension multi-centre trial in adult subjects diagnosed with Type 1 diabetes mellitus exploring the effect of long-term Verapamil SR therapy on the preservation of beta-cell function.

France, Belgium, Austria, Germany, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Evolution of proteinuria in renal transplant patients treated with Dapagliflozin for nephroprotection. DAPAGREFFE

France

Therapeutic use (Phase IV) EU CTIS Study details

Diabetic Ketoacidosis trials by city

Diabetic Ketoacidosis in Toronto Diabetic Ketoacidosis in Vancouver Diabetic Ketoacidosis in Montreal Diabetic Ketoacidosis in Calgary Diabetic Ketoacidosis in Edmonton Diabetic Ketoacidosis in Ottawa Diabetic Ketoacidosis in Winnipeg Diabetic Ketoacidosis in Quebec City Diabetic Ketoacidosis in Hamilton Diabetic Ketoacidosis in Kitchener Diabetic Ketoacidosis in London Diabetic Ketoacidosis in Halifax Diabetic Ketoacidosis in New York Diabetic Ketoacidosis in Los Angeles Diabetic Ketoacidosis in Chicago Diabetic Ketoacidosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease